Next-generation sequencing: FDA offers guidance to streamline path to market
The FDA on Thursday finalized two guidance documents related to next-generation sequencing (NGS) and drafted new guidance on investigational in vitro diagnostics (IVDs) in oncology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.